Frances Lauri Johnson

Title: Frances Lauri Johnson - Pioneer in Stem Cell Recruitment

Introduction

Frances Lauri Johnson is an innovative inventor based in Portola Valley, CA, with a focus on advancements in the field of stem cell therapy. With a portfolio of three patents, Johnson's work stands at the intersection of pharmacology and regenerative medicine.

Latest Patents

The latest patents attributed to Johnson are centered around the use of nicotine receptor agonists to enhance the recruitment of bone marrow-derived stem cells. Specifically, one of the key inventions outlines methods for mobilizing stem cells, such as endothelial cell precursors and hematopoietic stem cells, through the administration of nicotine or similar compounds. This groundbreaking research has the potential to transform the treatment landscape for conditions like neutropenia, where increasing the number of functioning blood cells is crucial.

Career Highlights

Frances Lauri Johnson is affiliated with Leland Stanford Junior University, where she contributes her expertise in stem cell research. Her career is marked not only by her inventive contributions but also by her commitment to advancing the understanding of how nicotine receptor agonists can be employed in clinical applications.

Collaborations

Throughout her career, Johnson has collaborated with notable colleagues, including John P Cooke and Anjali Pathak. This collaborative effort has strengthened the research outcomes and expanded the scope of innovations in their projects.

Conclusion

Frances Lauri Johnson represents a remarkable force in the realm of stem cell recruitment technologies. Through her patents and collaborative work, she continues to push the boundaries of what is possible in medical science, paving the way for new treatments that could significantly improve patient outcomes.